The FDA has just handed an advantage to GlaxoSmithKline’s triple therapy for chronic obstructive pulmonary disease (COPD) by rejecting AstraZeneca’s PT010, a close competitor. AZ has confirmed ...

They're essential for putting together a comfortable workwear outfit, and despite being "flat," are often secretly embedded with supportive features that make traveling by foot a little easier.